Clinique du Cap d’Or ELSAN
- Address
- 1361 Av. des Anciens Combattants d' Indochine, 83500 La Seyne-sur-Mer, France
Clinique du Cap d'Or ELSAN
Clinique du Cap d'Or ELSAN is a comprehensive oncology research center specializing in advanced cancer treatment protocols. The center demonstrates particular expertise in hormone-sensitive malignancies and precision oncology approaches, conducting innovative clinical trials that combine targeted therapies with molecular diagnostics.
- Advanced prostate cancer management with adjuvant hormonal therapy following radical prostatectomy
- Breast cancer precision medicine utilizing circulating tumor DNA (ctDNA) for ESR1 mutation detection
- Combination therapy strategies with palbociclib and endocrine therapy in metastatic breast cancer
The center's research portfolio reflects a commitment to optimizing treatment outcomes in patients with high-risk hormone-receptor positive cancers. Their investigations focus on both ER+/HER2- metastatic breast cancer and high-risk prostatic adenocarcinoma, employing sophisticated approaches including biomarker-driven treatment modifications and extended adjuvant hormonal strategies. The facility's expertise in evaluating long-term survival outcomes and sequential therapy administration positions it at the forefront of personalized cancer care.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Clinique du Cap d’Or ELSAN
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Adjuvant Pembrolizumab Versus Observation in Early Triple-Negative Breast Cancer with Pathologic Complete Response Post-Neoadjuvant Therapy | Unicancer | Phase III | Recruiting | Jul 2025 | — |
IMP list
lock Showing 1 of 7 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Anastrozole | 1 | Unknown | 2017-03-22 | 2017-03-22 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.